Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 908 Devices Inc.MASS · Entity 5564 | Director | June 10, 2026 | June 12, 2026 |
| DA32 Life Science Tech Acquisition Corp.DALS · Entity 110669 | Director | July 27, 2021 | July 27, 2021 |
| Quanterix CorpQTRX · Entity 6649 | Director · Executive Chairman | July 05, 2022 | July 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
908 Devices Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 165,390 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 14,083 · Balance 165,390 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Exercise / conversion · Disposed 14,083 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,656 |
Reported balance
After 2026-06-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-11 · Grant · Acquired 13,656 · Balance 13,656 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. |
| Stock Option (option to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.22 · Expires 2036-06-10 | Direct | 6,209 |
Reported balance
After 2026-06-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-11 · Grant · Acquired 6,209 · Balance 6,209 F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 329,675 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 329,675 F2: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
F2: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust.
F3: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
F4: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.
F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date.
DA32 Life Science Tech Acquisition Corp.
Report date July 27, 2021 · Filed July 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-27 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date.
Quanterix Corp
Report date July 05, 2022 · Filed July 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 910,249 |
Reported balance
After 2022-07-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-05 · Sale · Disposed 960 · Balance 910,249 F1: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs.
F2: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2020 Filed Jun 22, 2020 16:04 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 440 | $27.32 | $12,021.68 |
DisclosureSEC source: 0001562180-20-004615 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,079,637 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.26 to $27.37. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 185,255 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 16:04 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 5,060 | $26.84 | $135,803.82 |
DisclosureSEC source: 0001562180-20-004615 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,077 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.25 to $27.24. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 185,255 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 03, 2020 Filed Jun 3, 2020 18:59 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,300 | $27.06 | $62,246.51 |
DisclosureSEC source: 0001562180-20-004242 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,137 F4 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $26.60 to $27.57. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 185,255 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 03, 2020 Filed Jun 3, 2020 18:59 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,700 | $27.86 | $75,225.51 |
DisclosureSEC source: 0001562180-20-004242 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087,437 F4 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $27.60 to $28.045. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 185,255 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 18:59 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,331 | $27.32 | $90,997.59 |
DisclosureSEC source: 0001562180-20-004242 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,090,137 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.98 to $27.75. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 185,255 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 26, 2020 Filed May 28, 2020 16:35 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,500 | $25.97 | $90,893.25 |
DisclosureSEC source: 0001562180-20-003961 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093,468 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $25.495 to $26.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 26, 2020 Filed May 28, 2020 16:35 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,500 | $24.89 | $37,330.35 |
DisclosureSEC source: 0001562180-20-003961 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,968 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.45 to $25.41. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 11, 2020 Filed May 12, 2020 19:16 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 200 | $28.07 | $5,614.00 |
DisclosureSEC source: 0001562180-20-003562 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,468 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 11, 2020 Filed May 12, 2020 19:16 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,600 | $27.51 | $126,557.50 |
DisclosureSEC source: 0001562180-20-003562 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,668 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $27.05 to $28.00. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 11, 2020 Filed May 12, 2020 19:16 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 200 | $26.00 | $5,200.00 |
DisclosureSEC source: 0001562180-20-003562 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103,268 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 06, 2020 Filed May 8, 2020 16:35 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,800 | $27.55 | $77,127.96 |
DisclosureSEC source: 0001562180-20-003490 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103,468 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.03 USD to $27.97 USD; the price reported above reflects the weighted average sale price. F3 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 06, 2020 Filed May 8, 2020 16:35 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,200 | $26.51 | $58,328.60 |
DisclosureSEC source: 0001562180-20-003490 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106,268 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.02 USD to $26.97 USD; the price reported above reflects the weighted average sale price. F3 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 01, 2020 Filed May 4, 2020 17:22 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,399 | $25.44 | $86,478.04 |
DisclosureSEC source: 0001562180-20-003266 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,468 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · balance_after: Includes 192,378 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 23, 2020 Filed Apr 23, 2020 21:45 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,650 | $25.07 | $66,434.44 |
DisclosureSEC source: 0001562180-20-003106 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,867 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $25.05 to $25.11. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 23, 2020 Filed Apr 23, 2020 21:45 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,350 | $24.75 | $58,152.40 |
DisclosureSEC source: 0001562180-20-003106 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114,517 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $24.005 to $25.00. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 21:45 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,880 | $23.96 | $92,948.50 |
DisclosureSEC source: 0001562180-20-003106 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,867 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $23.55 to $24.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 21:45 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,120 | $22.68 | $25,402.27 |
DisclosureSEC source: 0001562180-20-003106 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120,747 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.49 to $23.38. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 09, 2020 Filed Apr 9, 2020 18:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 800 | $22.84 | $18,274.96 |
DisclosureSEC source: 0001562180-20-002973 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,867 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $22.27 to $23.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 09, 2020 Filed Apr 9, 2020 18:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,200 | $21.92 | $92,079.96 |
DisclosureSEC source: 0001562180-20-002973 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122,667 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $21.27 to $22.26. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 18:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,928 | $21.37 | $41,193.46 |
DisclosureSEC source: 0001562180-20-002973 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,126,867 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $21.18 to $21.57. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 18:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,072 | $20.51 | $63,003.34 |
DisclosureSEC source: 0001562180-20-002973 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,795 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.02 to $20.97. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 16:28 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 62 | $20.00 | $1,240.00 |
DisclosureSEC source: 0001562180-20-002882 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,867 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:28 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 5,438 | $20.02 | $108,868.76 |
DisclosureSEC source: 0001562180-20-002882 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,929 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.00 to $20.09. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 17:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,233 | $17.44 | $56,399.04 |
DisclosureSEC source: 0001562180-20-002853 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137,367 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.12 to $17.76. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 199,501 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 16:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 5,500 | $20.53 | $112,915.00 |
DisclosureSEC source: 0001562180-20-002429 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,140,600 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.37 to $20.54. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 206,624 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 310 | $22.97 | $7,121.38 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,100 F6 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 661 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $22.90 to $22.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · balance_after: Includes 206,624 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,020 | $22.93 | $69,234.71 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,410 F4 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 6,462 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $22.90 to $22.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,135 | $22.86 | $25,941.45 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,430 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.83 to $23.20. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,365 | $22.40 | $97,782.55 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,565 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.83 to $22.80. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:18 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 90,992 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001435 · primarydocument.xml · derivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,992 Underlying: Common Stock · 90,992 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:18 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 38,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001435 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154,930 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 213,747 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 19:58 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 6,500 | $27.17 | $176,614.10 |
DisclosureSEC source: 0001562180-20-001259 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115,933 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.66 to $27.65. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 174,750 restricted stock units. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 16:15 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 6,500 | $27.56 | $179,140.00 |
DisclosureSEC source: 0001562180-20-001011 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122,433 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.14 to $28.12. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 174,750 restricted stock units. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 16:28 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,409 | $26.71 | $64,344.39 |
DisclosureSEC source: 0001562180-20-000894 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,933 F3 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F4 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 174,750 restricted stock units. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 16:28 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 600 | $27.48 | $16,488.00 |
DisclosureSEC source: 0001562180-20-000894 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,342 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 16:28 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 5,900 | $27.05 | $159,569.04 |
DisclosureSEC source: 0001562180-20-000894 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,942 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.44 to $27.40. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 29, 2020 Filed Jan 29, 2020 19:54 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 6,500 | $26.99 | $175,407.05 |
DisclosureSEC source: 0001562180-20-000682 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137,842 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.70 to $27.31. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 17:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 6,500 | $24.07 | $156,443.95 |
DisclosureSEC source: 0001562180-20-000481 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,144,342 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.93 to $24.20. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 17, 2020 Filed Jan 17, 2020 20:40 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 6,500 | $24.41 | $158,665.00 |
DisclosureSEC source: 0001562180-20-000433 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,842 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 20:40 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 6,500 | $22.17 | $144,129.70 |
DisclosureSEC source: 0001562180-20-000433 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157,342 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.05 to $22.25. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,321 | $23.18 | $76,965.50 |
DisclosureSEC source: 0001562180-20-000211 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,163,842 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.96 to $23.42. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 20:29 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,357 | $25.06 | $84,136.16 |
DisclosureSEC source: 0001562180-19-005807 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167,163 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.99 to $25.13. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 188,996 restricted stock units. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 16:13 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,336 | $20.86 | $69,586.96 |
DisclosureSEC source: 0001562180-19-005324 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170,520 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.79 to $20.92. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 196,119 restricted stock units. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 16:05 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,336 | $21.78 | $72,658.08 |
DisclosureSEC source: 0001562180-19-005048 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,173,856 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 203,242 restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 16:57 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,362 | $25.97 | $87,314.50 |
DisclosureSEC source: 0001562180-19-004671 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177,192 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.92 to $26.085. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 210,365 restricted stock units. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 16:14 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 523 | $26.58 | $13,901.34 |
DisclosureSEC source: 0001562180-19-004479 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180,554 F1 · kind: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 1,061 RSUs. F2 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 217,488 restricted stock units. Read SEC document |
| August 17, 2019 Filed Aug 20, 2019 16:00 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001562180-19-004401 · primarydocument.xml · derivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-08-17 F3 · derivative.exercise_date: The option vested as to 4,166 shares immediately upon grant, and vests as to an additional 833.333 shares at the end of each month thereafter starting on August 31, 2019 for 43 months, subject to Mr. Hrusovsky's continued service as Chief Executive Officer. Read SEC document |
| August 17, 2019 Filed Aug 20, 2019 16:00 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 10,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-004401 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181,077 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vested as to 1,061 shares immediately upon grant, and vest as to an additional 212.375 shares at the end of each month thereafter starting on August 31, 2019 for 43 months, subject to Mr. Hrusovsky's continued service as Chief Executive Officer. F2 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 218,549 restricted stock units. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:22 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 303 | $31.62 | $9,579.44 |
DisclosureSEC source: 0001562180-19-004148 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170,883 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and 661 RSUs, respectively. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.55 to $31.795. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 16:22 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,864 | $31.62 | $90,546.22 |
DisclosureSEC source: 0001562180-19-004148 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,171,186 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and 661 RSUs, respectively. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.55 to $31.795. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 208,355 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.